VERTEX PHARMACEUTICALS INC / MA 4
4 · VERTEX PHARMACEUTICALS INC / MA · Filed Jun 9, 2017
Insider Transaction Report
Form 4
BOGER JOSHUA S
DirectorCEO
Transactions
- Exercise/Conversion
Common Stock
2017-06-08+2,941→ 284,088 total - Exercise/Conversion
Deferred Stock Units
2017-06-08−2,941→ 0 total→ Common Stock (2,941 underlying)
Holdings
- 13,286(indirect: By 401(k))
Common Stock
- 64,525(indirect: By Trust)
Common Stock
Footnotes (1)
- [F1]Each deferred stock unit represents one share of common stock and converted into common stock upon the termination of Dr. Boger's service on our board of directors on 06/08/2017.